Neoadjuvant radiotherapy and chemotherapy in localy advanced rectal cancer (CROSBI ID 308490)
Prilog u časopisu | izvorni znanstveni rad | domaća recenzija
Podaci o odgovornosti
Fröbe, Ana ; Marić-Brozić, Jasmina ; Soldić, Željko ; Bolanča, Ante ; Zovak, Mario ; Jones, Glenn ; Rosenblatt, Eduardo ; Đaković, Nikola
hrvatski
Neoadjuvant radiotherapy and chemotherapy in localy advanced rectal cancer
At the Department of Oncology and Nuclear Medicine UHC “Sestre milosrdnice” patients who had advanced rectal cancer were treated with preoperative radiotherapy and chemotherapy, in cooperation with the IAEA and ESTRO. Fifteen patients who met the criteria and signed informed consent were included. Patients were randomized into two groups: Group 1: standard group, neoadjuvant approach (chemotherapy 5-FU / leucovorin concomitantly with radiotherapy (45-50 Gy in 25 fractions) ; Group 2: short course group, chemotherapy 5-FU / leucovorin with radiotherapy (25 Gy in 5 fractions). The main objectives were to determine the rate of resectability after completion of neoadjuvant therapy and to determine the percentage of local control and overall survival.
neoadjuvant therapy ; locally advanced rectal cancer
nije evidentirano
engleski
Neoadjuvant radiotherapy and chemotherapy in localy advanced rectal cancer
At the Department of Oncology and Nuclear Medicine UHC “Sestre milosrdnice” patients who had advanced rectal cancer were treated with preoperative radiotherapy and chemotherapy, in cooperation with the IAEA and ESTRO. Fifteen patients who met the criteria and signed informed consent were included. Patients were randomized into two groups: Group 1: standard group, neoadjuvant approach (chemotherapy 5-FU / leucovorin concomitantly with radiotherapy (45-50 Gy in 25 fractions) ; Group 2: short course group, chemotherapy 5-FU / leucovorin with radiotherapy (25 Gy in 5 fractions). The main objectives were to determine the rate of resectability after completion of neoadjuvant therapy and to determine the percentage of local control and overall survival.
neoadjuvant therapy ; locally advanced rectal cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
530 (44)
2017.
89-101
objavljeno
1330-5301
1848-641X
10.21857/yvjrdcn3zy